September 16, 2009 – Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin, Texas plans to create a worldwide electrophysiology (EP) telecardiology network for live consultations with other EP labs anywhere in the world using the Odyssey Network offered by Stereotaxis.

September 15, 2009 – EVEREST registry clinical results of the MitraClip therapy for patients with mitral regurgitation (MR) will be a big topic of discussion at the Transcatheter Cardiovascular Therapeutics (TCT) Conference Sept. 21-25 in San Francisco.

September 16, 2009 – MemorialCare Heart and Vascular Institute at Long Beach Memorial Medical Center (LBMMC) in Long Beach, Calif., said it implanted a new, heart attack detection device in two heart attack survivors yesterday.

September 16, 2009 – Hansen Medical Inc. today said it received FDA clearance for its next generation Sensei X Robotic Catheter System and it introduced the Artisan Extend Control Catheter. The company also plans to introduce the Lynx Robotic Ablation Catheter, a small, flexible irrigated ablation catheter, for customers in Europe this fall.

September 15, 2009 – Tryton Medical Inc. said today its Tryton Side Branch Stent has been used in 250 procedures to treat atherosclerotic lesions at bifurcations in patients with heart disease.

September 15, 2009 – Bracco is hosting a breakfast symposium at TCT 2009, “Evidence-Based Selection of Contrast Media in Interventional Cardiology,” for interventional cardiologists, cardiologists, nurses and technologists, informing them of the latest clinical evidence for contrast-induced nephropathy, including risk factors and best treatment options.

September 15, 2009 – Spacelabs Healthcare today announced the U.S. launch of Sentinel, a sophisticated cardiology information management systems (CIMS), which facilitates analysis and reporting while also improving efficiency and eliminating errors.


September 15, 2009 – Fluid monitoring with OptiVol Fluid Status Monitoring is a more accurate predictor of worsening heart failure compared to daily weight monitoring in heart failure patients with implantable devices, according to results released yesterday from the FAST (Fluid Accumulation Status Trial) clinical trial.

September 15, 2009 – St. Jude Medical Inc. said yesterday the U.S. Food and Drug Administration (FDA) cleared and U.S. launch of the EnSite Velocity Cardiac Mapping System, which is designed to help physicians more efficiently diagnose and guide therapy to treat abnormal heart rhythms.

September 15, 2009 - Positron Corp. announced that the Ministry of Health and Long Term Care of Ontario, Canada is making positron emission tomography (PET) scanning a publicly insured health service available to cancer and cardiac patients under conditions where PET scans have been proven to be clinically effective.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now